APFED Launches EoE Awareness Campaign in New York City’s Iconic Times Square

New series of digital advertisements will educate visitors about eosinophilic esophagitis (EoE) and its symptoms

ATLANTA, GA —The American Partnership for Eosinophilic Disorders (APFED) is pleased to announce a campaign to boost awareness of eosinophilic esophagitis (EoE) in one of the most recognizable advertising venues—Times Square in New York City.  To educate the public about the symptoms of EoE and prompt them to learn more if they recognize symptoms, APFED is running a disease awareness campaign in Times Square from April 1, 2023, through June 30, 2023.

The campaign will appear on a digital billboard located five stories above the northeast corner of the intersection at 1500 Broadway and West 43rd Street.

Awareness of eosinophilic esophagitis (EoE) is essential for early detection and is key to ensuring patients are offered effective treatment in a timely fashion. EoE is a chronic, allergic inflammatory disease of the esophagus (the tube connecting the mouth to the stomach). It occurs when a type of white blood cell, the eosinophil, accumulates in the esophagus. The elevated number of eosinophils cause injury and inflammation to the esophagus. This damage may make eating difficult or uncomfortable, potentially resulting in poor growth, chronic pain, and/or difficulty swallowing.

“This campaign is an excellent opportunity to reach a diverse population to educate them about the symptoms of EoE,” shared APFED’s Executive Director Mary Jo Strobel. “The April-June timeframe also aligns with our patient community’s increased efforts to raise awareness during National Eosinophil Awareness Week (May 14-20, 2023) and World Eosinophilic Diseases Day (May 18).”

APFED is grateful to Sanofi and Regeneron for their support of the campaign.

About the American Partnership for Eosinophilic Disorders (APFED)

The American Partnership for Eosinophilic Disorders (APFED) is a non-profit organization whose mission is to passionately embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy. apfed.org

 

###